Comparing Tilray Brands (NASDAQ:TLRY) and InterCure (NASDAQ:INCR)Defense World · Sep 30, 2026
InterCure Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewsWire · Sep 8, 2026
InterCure (NASDAQ:INCR) & Silo Pharma (NASDAQ:SILO) Financial ReviewDefense World · Sep 8, 2026
InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect DamagesGlobeNewsWire · Aug 24, 2026InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil.